We are live on
!
Find out more
Atara Biotherapeutics
ATRA
ATRA
114 hedge funds and large institutions have $1.7B invested in Atara Biotherapeutics in 2018 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 50 increasing their positions, 16 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
471% more call options, than puts
Call options by funds: $32.2M | Put options by funds: $5.64M
290% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 10
227% more capital invested
Capital invested by funds: $519M → $1.7B (+$1.18B)
213% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 16
33% more funds holding
Funds holding: 86 → 114 (+28)
0.59% more ownership
Funds ownership: 3.9% → 4.49% (+0.59%)
Holders
114
Holders Change
+28
Holders Change %
+32.56%
% of All Funds
2.61%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.07%
New
39
Increased
50
Reduced
16
Closed
10
Calls
$32.2M
Puts
$5.64M
Net Calls
+$26.5M
Net Calls Change
+$28.6M
Top Buyers
Top Sellers
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$62.4M |
| 2 |
RI
RTW Investments
New York
|
-$10.1M |
| 3 |
1WCM
12 West Capital Management
New York
|
-$8.02M |
| 4 |
NC
Nexthera Capital
New York
|
-$5.19M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$4.92M |
